The article entitled “First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations (https://doi.org/10.1056/NEJMoa2604461)”, authored by Prof. Dr. Ozan Yazıcı, a faculty member in the Department of Internal Medicine, Faculty of Medicine, and colleagues, was published in New England Journal of Medicine, which is among the top 500 journals in SSCI and has a WoS impact factor of 84.5.

We congratulate them for their international, industry and university collaborative publications and wish them continued success.